Immunotherapy

ImmunoACT, backed by Laurus Labs is testing their cancer product

Some oncologists choose not to mention immunotherapy to dying patients, arguing that scientists first must gather rigorous evidence about the benefits and pitfalls

Due to this trial, lesser insulin is needed to control people's blood glucose levels

With promising results, such new weapons are providing hope that cancer can ultimately be defeated